Sharon Robertson Named to 2022 “40 & Under” List

Benchmark Litigation

July 29, 2022

Every year, Benchmark Litigation sets out to identify the best and brightest litigators under the age of 40 across the United States and Canada. This year’s list includes Sharon K. Robertson, a Partner in Cohen Milstein’s Antitrust practice group.

Ms. Robertson is a nationally recognized leader in complex, multi-district antitrust litigation, particularly in pharmaceutical antitrust class actions, and is consistently ranked among the top antitrust practitioners in the U.S. by Chambers USA, Legal 500, Law360, the National Law Journal, and other peer-reviewed rankings. Ms. Robertson also spearheads the firm’s efforts in pay-for-delay pharmaceutical antitrust lawsuits, a cutting-edge and industry-defining area of law, which allege that the defendant brand manufacturer entered into non-competition agreements with generic manufacturers in order to delay entry of lower-priced generic products. Ms. Robertson also heads up the firm’s generic price-fixing cases, which allege that certain generic drug manufacturers conspired to inflate the prices of generic drug products. 

In addition to leading complex MDLs, Ms. Robertson is an accomplished trial lawyer. She served as a trial team member in two of the largest antitrust cases tried to verdict, including In re Urethanes Antitrust Litigation, where the jury returned a $400 million verdict, which was trebled by the Court, as required by antitrust law, resulting in the largest price-fixing verdict in U.S. history, as well as In re Nexium Antitrust Litigation, the first pharmaceutical antitrust case to go to trial following the Supreme Court’s landmark decision in FTC v. Actavis, 570 U.S. 756 (2013).